Dingell generic drug probe
Executive Summary
House Commerce/Oversight & Investigations Subcommittee plans to interview more than the 60 FDA employees it had initially targeted for questioning in its investigation into the agency's generic drug approval process. The subcommittee, chaired by Rep. Dingell (D-Mich.), expects to finish first round of interviews, including the 60 FDAers, during the week ending April 8. Dingell has said that the interviews are necessary due to the expansion of the generic drug approval inquiry launched last summer ("The Pink Sheet" March 20, p. 3).
You may also be interested in...
In Flood Of 2020 Sanitizer Launches, Unilever’s Suave Brand Tops US Category Sales
Unilever’s Suave brand led new sanitizer product sales in 2020, when hand sanitizers total sales grew 569%, according to IRI. Sales of rinseable hand-soap sales grew 64% and antiseptics 19%.
Turkish Medtechs Face The Constant Challenge Of Sailing In Stormy Seas
The pandemic has exacerbated the problems of the Turkish medical device industry, which was already struggling for survival and growth in a hostile policy environment. Local blood bag manufacturer Kansuk Laboratory talked to Medtech Insight about the difficulties it faces.
Pipeline Watch: Phase III Readouts For COVID-19, Dry Eye Disease, Uveal Melanoma
Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.